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Development of an easily interpretable presentation format for meta-analyses in 
periodontal surgery 
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Problem: The comparison of two therapies is important for dentists in order to support 
the decision on treatment options available in practice. Meta-analyses already exist for 
the comparison of regenerative periodontal therapies. For example, guided tissue 
regeneration treatments (GTR) using membranes or enamel matrix derivatives have been 
compared to conservative open flap debridement without membranes (referred to as 
standard treatment below). However, treatment effects are expressed, for example, as 
millimetre changes in probing pocket depth (for example, weighted mean difference of 
1.21 mm probing depth reduction for GTR compared to conservative open flap 
debridement1). Such treatment effects are rather difficult to interpret for the practitioner 
because the clinical relevance of these changes is not well understood. In contrast, 
eliminating the pockets (to ≤3 mm) is considered to be a clinical success. Therefore, it 
would be easier to have an estimate how more likely a clinical success is achieved with 
treatment A compared to treatment B. 
 
Objective: Our aim was to develop a presentation format for meta-analyses that is easy to 
interpret for dentists in situation where there is an agreed-on definition of clinical 
success. 
 
Methods: We re-analysed 2 meta-analyses that included randomised trials and that were 
reported in Tu et al.2. One of them compared GTR (15 trials) with open flap debridement 
without additional membranes and the other one the use of enamel matrix derivatives (10 
trials) with open flap debridement without additional membranes. From each study, we 
extracted the number of patients as well as the mean pocket depths and their standard 
deviation at follow-up. We had to exclude some of these studies (5 GTR and one enamel 
matrix derivative trial) for our meta-analysis because they only calculated and reported 
differences between baseline values and follow-up values but did not report on mean 
changes and standard deviations that were necessary for our analysis. We then calculated 
the number of patients with pocket depths ≤ or >3 mm as follows: We assumed that the 
pocket depths at follow-up were distributed normally. Based on the mean pocket depths 
and their standard deviation, we calculated probabilities for clinical success, i.e. for 
pockets ≤3 mm. The formula is explained in the appendix. Based on these probabilities, 
the number of patients with and without clinical success (≤3 or >3 mm) were calculated 
by multiplying the number of patients by the calculated probabilities. Using the resulting 
proportion of patients with and without clinical success we used random-effects metaanalysis 
to estimate pooled odds ratios for clinical success. 
 
 
 
Results: The mean probability for clinical success was 43% for GTR, 26% for the use of 
enamel matrix derivative and 13% for standard treatment. GTR was highly effective to 
reduce pockets compared with standard treatment (pooled odds ratio 6.4, 95% confidence 
interval 2.9-14.0, I2= 51% = moderate to large between-study heterogeneity). Enamel 
matrix derivative were only slightly more effective than the standard treatment (pooled 
odds ratio: 1.6, 1.0-2.5, I2=0%= no between-study heterogeneity). 
 
Conclusion: The meta-analyses showed that GTR increased the chance for clinical 
success by about six-fold compared to standard treatment whereas enamel matrix 
derivatives were only slightly better than standard treatment. This alternative of analyzing 
and presenting randomized trials offers a much easier interpretation than a presentation of 
weighted mean differences in millimeter changes. In addition, the calculation of 
probabilities, based on the assumption of normality is simple. 
A weakness of our approach is that the calculated probabilities are based on the 
assumption that the data are distributed normally. This cannot be verified without having 
access to the original data. If data are not distributed normally some misclassification will 
occur. However, randomisation might minimize this problem because the extent of 
misclassification is likely to be similar in the treatment groups. 
In general, it is more adequate keep continuous data and not to dichotomize them because 
continuous data carry more information. However, in situations where interpretation of 
continuous outcomes are difficult and where clear cut-offs for clinical success exists, a 
transformation as described above can facilitate interpretation substantially. Of course, 
the most adequate analysis would be based on randomised trials that reported the number 
of patients with and without clinical success themselves. However, since it is unrealistic 
that all studies report clinical success rates our approach proposes a solution to present 
the results of meta-analyses in a more easily understandable format. 
 
Appendix 
The formula for the calculation of the probabilities P(X≤x) for clinical success, i.e. for 
pockets ≤3 mm is as follows: P(X≤x) = F(X)(x) = Φ ((x-µ)/σ) with F(X)(x) as the 
cumulative distribution function, µ as the mean, σ as the standard deviation and x as the 
cutoff-value, i.e. in our example 3mm. For the expression Φ ((x-µ)/σ), one can receive 
the probabilities by consulting normal distribution tables as described in Stahel3. Φ stands 
for the distribution function of the standard normal distribution.. The probability values in 
the tables as described in Stahel3 are only valid for standard normal distribution. 
For example, for a group of 9 patients the mean pocket depth at follow-up is 3.53 with a 
standard deviation of 0.62. For Φ ((x-µ)/σ), we get ((3-3.53)/0.62) = -0.85. The 
probability for pockets ≤3 mm is, as derived from the table in Stahel3, 0.20. Hence the 
number of patients with pockets ≤3 mm is 9*0.20 = 2 and the number of patients with 
pockets >3mm is 0.80*9 = 7. 
 
Literature 
1. Needleman IG, et al. Guided tissue regeneration for periodontal infra-bony 
defects (Review). Cochrane Database of Systematic Reviews 2006:1-27. 
2. Tu Y-K. ea. Is there a temporal trend in the reported treatment efficacy of 
periodontal regeneration? A meta-analysis of randomizedcontrolled trials. Journal 
of Clinical Periodontology 2008;35:139–146. 
3. Stahel W. Statistische Datenanalyse – Eine Einführung für Naturwissenschaftler: 
Braunschweig/Wiesbaden, 2002. 
  
